CANNABIDIOL ADJUNCTIVE THERAPY FOR ACUTE BIPOLAR DEPRESSION: A RANDOMIZED DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL

Registry ID

CBD-BD-01

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

DR. LAKSHMI YATHAM

Start date

2025-01-17

Last update

2023-03-08

Conditions

• BIPOLAR DEPRESSION

Related clinical trials

• NEUROBIOLOGICAL EFFECTS OF PSILOCYBIN IN TREATMENT RESISTANT BIPOLAR DEPRESSION: AN EMOTIONAL-PROCESSING FMRI PILOT STUDY
• MAINTENANCE KETAMINE INFUSIONS FOR TREATMENT-RESISTANT BIPOLAR DEPRESSION: AN OPEN-LABEL EXTENSION TRIAL
• NEURAL CORRELATES OF ANTI-SUICIDAL RESPONSE TO KETAMINE IN TREATMENT RESISTANT BIPOLAR DEPRESSION (DEEPP-STUDY). PILOT PROJECT
• LOW-DOSE ADJUNCTIVE BREXPIPRAZOLE IN THE TREATMENT OF BIPOLAR I AND II DEPRESSION: AN OPEN-LABEL STUDY
• A MULTIPLE-DOSE, COMPARATIVE BIOAVAILABILITY STUDY OF TWO FORMULATIONS OF QUETIAPINE 400 MG PROLONGED RELEASE TABLETS UNDER FASTING CONDITIONS IN SUBJECTS WITH PRIMARY PSYCHOTIC AND/OR BIPOLAR DISORDER

View on source registry